JamesEHarrisonMD

PubMed

• Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
  Hughes, Z. A.,Neal, S. J.,Smith, D. L.,Sukoff Rizzo, S. J.,Pulicicchio, C. M.,Lotarski, S.,Lu, S.,Dwyer, J. M.,Brennan, J.,Olsen, M.,Bender, C. N.,Kouranova, E.,Andree...> ;Neuropharmacology. 2013 Mar
• Measuring the Population Burden of Fatal and Nonfatal Injury.
  Polinder, S., Haagsma, J.A., Lyons, R.A., Gabbe, B.J., Ameratunga, S., Cryer, C., Derrett, S., Harrison, J.E., Segui-Gomez, M., van Beeck, E.F.> ;Epidemiol Rev. 2012 Jan
• Classifying External Causes of Injury: History, Current Approaches, and Future Directions.
  McKenzie, K., Fingerhut, L., Walker, S., Harrison, A., Harrison, J.E.> ;Epidemiol Rev. 2012 Jan
• The global injury mortality data collection of the Global Burden of Disease Injury Expert Group: a publicly accessible research tool.
  Bhalla, K., Harrison, J.E., Fingerhut, L.A., Shahraz, S., Abraham, J., Yeh, P.> ;Int J Inj Contr Saf Promot. 2011 Sep
• Modelling Long Term Disability following Injury: Comparison of Three Approaches for Handling Multiple Injuries.
  Gabbe, B.J., Harrison, J.E., Lyons, R.A., Jolley, D.> ;PLoS One. 2011
• 1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.
  Vu, A.T., Cohn, S.T., Zhang, P., Kim, C.Y., Mahaney, P.E., Bray, J.A., Johnston, G.H., Koury, E.J., Cosmi, S.A., Deecher, D.C., Smith, V.A., Harrison, J.E., Leventhal,...> ;J Med Chem. 2010 Mar 11
• The role of design issues in work-related fatal injury in Australia.
  Driscoll, T.R., Harrison, J.E., Bradley, C., Newson, R.S.> ;J Safety Res. 2008
• Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states.
  Ilyin, V.I., Pomonis, J.D., Whiteside, G.T., Harrison, J.E., Pearson, M.S., Mark, L., Turchin, P.I., Gottshall, S., Carter, R.B., Nguyen, P., Hogenkamp, D.J., Olanrewa...> ;J Pharmacol Exp Ther. 2006 Sep
• DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid ago...
  Whiteside, G. T., Harrison, J. E., Pearson, M. S., Chen, Z., Fundytus, M. E., Rotshteyn, Y., Turchin, P. I., Pomonis, J. D., Mark, L., Walker, K., Broglé, K. C.> ;J Pharmacol Exp Ther. 2004 Aug
• N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analge...
  Pomonis, J.D., Harrison, J.E., Mark, L., Bristol, D.R., Valenzano, K.J., Walker, K.> ;J Pharmacol Exp Ther. 2003 Jul
• Join now to see all